11-13 November 2025
Congress Center BaselBasel, Switzerland Anders Gabrielsen, PhDVP - Head of Global Clinical Development at Ribocure PharmaceuticalsSpeaker
Profile
| Dr Anders Gabrielsen, MD, DMSc, FESC, Ribocure Pharmaceuticals, Vice President and Head of Global Clinical Development, is an experienced physician-scientist with almost 15 years of industry expertise in the cardiovascular, renal, and metabolism therapy area. Obtained MD and DMSc at University of Copenhagen, Associate Prof in Cardiology, translational research and clinical cardiologist and internist at Karolinska Institutet and Karolinska University Hospital, Sweden. Dr Gabrielsen has played key roles in core clinical teams across all aspects of cardiology and internal medicine, with a focus on translational cardiovascular science and clinical development. Prior work spans across multiple mechanisms of action and modalities, indications and product launches, with global industry and executive director experience from leading pharmaceutical companies such as Bayer, Novartis, and AstraZeneca. |
Agenda Sessions
First-in-human Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of RBD4059, a GalNAc-siRNA Drug Targeting Coagulation Factor XI (FXI), in Healthy Subjects
, 16:15View Session